Background Neonatal septicemia constitutes an important cause
Methods A prospective study conducted on newborn babies delivered in Cipto Mangunkusumo Hospital, Jakarta from July 2004-May 2005 who presented clinical signs of septicemia were subjected for blood culture. Those sensitive to antibiotics for 7 days yet showed no clinical improvement were also cultured for fungi.
Results A total of 499 blood cultures were taken, 320 were positive for bacteria (positivity rate was 65.3%). There were 192 samples cultured for fungi, and the positivity rate was 64% (all for Candida sp). Acinetobacter calcoaceticus was the most common bacteria found (35.7%) , followed by Enterobacter sp (7.0%) , and Staphylococcus sp (6 
.8%). Most bacteria showed high degrees of resistance to commonly used antibiotics (ampicillin and gentamicin). There were also high degrees of resistance to cephalosporins by both Gram negative and Gram positive organisms. Only 61.7% of A. calcoaceticus, and 45.7% of Enterobacter sp were sensitive to ceftazidime. Gram negative organisms were also highly resistant to amikacin, but Staphylococcus sp was only moderately resistant. Resistance to carbapenem (meropenem and imipenem) varied from moderate to low. Drugs which were not used for newborn babies (quinolones/ciprofloxacin and chloramphenicol) varied from moderate to high resistance.
Conclusion Neonatal sepsis remains one of the major causes of mortality in our neonatal unit. Most organisms have developed multidrug resistance, and management of patients infected with these organisms and especially those with fungi infection are becoming a problem in developing countries Keywords: multidrug resistance, neonatal sepsis N eonatal sepsis is one of the most common reasons for admission to neonatal units in developing countries. 1, 2 In Cipto Mangunkusumo Hospital, Jakarta, more than 95% admissions to the unit are inborn, of whom 70% were unbooked deliveries. The annual number of admissions in Cipto Mangunkusumo Hospital is about 680 per year, sepsis accounts for almost 40% of the admissions. Neonatal sepsis is also a major cause of mortality in both developed and developing countries. 2, 3 Gram negative organisms remain the major cause of neonatal sepsis in most developing countries. 1, [4] [5] [6] [7] [8] [9] [10] During the 1960s, in Europe and America, Gram negative organisms were the most common cause of neonatal sepsis. This altered to group B streptococcus during the 1970s and coagulase-negative staphylococcus during the late 1980s and 1990s. 1, [4] [5] [6] [7] [8] [9] [10] This is due to the changing pattern of antibiotic use and changes in lifestyle. The most disturbing thing was that these organisms have developed increasing multidrug resistance over the last two decades, 8, [9] [10] [11] due to the indiscriminate and inappropriate use of antibiotics, over with clinical signs of septicemia. Babies who had received antibiotics before admissions were excluded.
Blood was taken by a standard method and cultured for bacteria in the Microbiology Clinical Pathology Laboratory at Cipto Mangunkusumo Hospital. Those sensitive to antibiotics for 7 days, but still showed no clinical improvement, were also cultured for fungi in the Parasitology laboratory at Cipto Mangunkusumo Hospital. Sensitivity to various antibiotics was tested by a standard disc diffusion technique, yet was not done to various antifungals due to limited budget. Figure 1) . No group B streptococcus was grown from any culture. Table 1 the counter sale of antibiotics, lack of legislation to control their use, poor sanitation, and ineffective infection control in the maternity services. 12 Furthermore excessive antibiotic use causes neonatal fungal sepsis. Studies have consistently shown the duration of antibiotic use, particularly broad spectrum antibiotics, is the major risk factor for neonatal fungal infection. 13, 14 The rapid emergence of multidrug resistant neonatal sepsis in developing countries is a new potential threat to the survival of newborn babies, who are often already in poor condition.
Results

Blood
This study was done to investigate the spectrum of organisms which cause neonatal sepsis and assess their sensitivity to various groups of drugs in the neonatal unit.
Methods
This was a prospective study carried out in the Neonatal Unit at Cipto Mangunkusumo Hospital, Jakarta 
Discussion
About five million neonatal deaths occur worldwide each year, 98% of which occur in developing countries, particularly Asia and Africa. Infections such as tetanus, pneumonia, septicemia, meningitis, and diarrhea account for 30-50% of neonatal deaths in developing countries. 15 Neonatal sepsis is a life threatening emergency and any delay in treatment may result in death.
The spectrum of organisms which cause neonatal sepsis changes over time and varies from region to region. It can also vary from hospital to hospital in the same city. This is due to the changing pattern of antibiotic use and changes in lifestyle. The most common organisms which cause early and late onset sepsis in our study are very similar, which were Gram negative Acinetobacter calcoaceticus, Enterobacter sp, Staphylococcus sp, Klebsiella sp, and Pseudomonas sp. Siswanto et al, 16 from Harapan Kita Children's and Maternity Hospital, Jakarta; reported that Serratia sp is the leading cause of Gram negative sepsis. Suarca et al, 17 from Sanglah Hospital, Denpasar, Bali, found that Enterobacter sp are responsible for most cases. Joshi et al, 8 from India, reported Gram negative sepsis in 67.2% of their cases, with Pseudomonas aeruginosa being the most common organism (38.3%), followed by Klebsiella (30.4%) and E. coli (15.6%). Similar patterns have been reported in Trinidad and Southern Israel. 5, 6 Staphylococcus sp was the most common Gram positive organisms (6.8%) in our study. Similar results have been reported by Siswanto et al, 16 Jakarta. While Suarca 17 found coagulase-positive staphylococcus (25.0%) as the most common Gram positive bacteria, followed by coagulase-negative staphylococcus (9.6%).
Group B streptococcus was not isolated from any culture in our series. The same result has been reported in most of the studies from Indonesia, Pakistan, and other developing countries. [1] [2] [3] [4] 8, 9, 16, 17 Ghiorgis 18 from Ethiopia did not find any group B streptococcus. On the other hand, in the series reported by Robbilard et al, 19 from Guadeloupe, group B streptococcus was grown from 46% of positive blood cultures, and 52% of gastric aspirates were positive for group B streptococcus. In Al Wasl Hospital, Dubai, Koutouby and Habib Ullah, 20 found 106 positive culture cases of neonatal sepsis with group B streptococcus being the most common organism (23%), particularly in early onset and late onset neonatal sepsis. Ohlsson et al 21 were the first to report the emergence of group B streptococcus in Saudi Arabia in the early 1980s.
The antimicrobial sensitivity pattern differs in different studies as well as at different times in the same hospital. [22] [23] [24] This is due to the emergence of resistant strains as a result of indiscrimate use of antibiotics. Indonesia has an enormous and growing problem of antibiotic use and abuse in newborn care. Simi- lar problems of antibiotic resistance have been reported in many countries, including both industrialised countries (North America, Europe, and Australia) and in developing countries. [25] [26] [27] [28] [29] [30] However, it seems that the situation is especially severe in Indonesia as it has reached the crisis level.
First Line
Our study showed a very high degree of resistance in Gram negative organisms to first line antibiotics (ampicillin), and 62.9%-94.7% resistance to gentamicin. About 97.1% of Staphylococcus sp were resistant to ampicillin. Suarca et al 17 from Denpasar, Bali, also reported the same result.
There was also a high degree of resistance to cephalosporins in both Gram negative and Gram positive organisms. Only 61.7% of Acinetobacter calcoaceticus and 45.7% of Enterobacter sp were sensitive to ceftazidime. Gram negative organisms were also highly resistant to amikacin, but Staphylococcus sp was only moderately resistant. The data of Anwer et al 1 from Karachi showed 80% resistance to ampicillin yet only 11-13% resistance to cefotaxime and 0-10% resistance to amikacin. Our study also showed that the resistance of A. calcoaceticus, Enterobacter sp, and Klebsiella sp to carbapenem, meropenem, and imipenem was low, yet the resistance of Pseudomonas sp (26.7%) and Staphylococcus sp (38.2%) was moderate. There was a high degree of resistance to quinolones, particularly ciprofloxacin. Acinetobacter calcoaceticus showed high sensitivity to chloramphenicol. Maryam et al, 9 from the Children's Hospital in Lahore reported that Gram positive (Staphylococcus sp) showed more resistance to quinolones yet Gram negative bacteria showed low resistance.
Emerging multiple drug resistance has also been reported in other parts of the world. Data of Orrett and Shurland 5 from Trinidad showed 85% of S. aureus are resistant to ampicillin, and Pseudomonas was 76.6% resistant to ceftazidime and 72.1% resistant to gentamicin. Joshi et al 8 from India showed a predominance of Gram negative bacteremia (67.2%) in their series, which had 25-75% resistance to cephalosporins, 68-78% resistant to piperacillin, and 23-69% resistant to gentamicin.
Friedman et al 11 from Toronto isolated ampicillin resistant E. coli from 75% of infants with early onset neonatal sepsis and 53% from a group with late onset neonatal sepsis. Gentamicin resistance was found in 50% if the early onset group and 16% of the late onset group. Kaushik et al 31 reported their bacterial isolates to be resistant to penicillin, ampicillin, and gentamicin, but had good sensitivity towards third generation cephalosporins and netilmicin. Leibovitz et al 32 reported the appearance of extremely virulent multiresistant Klebsiella in their neonatal intensive care unit at Kaplan Hospital, Israel. Kokasal et al 33 from India, reported a series of 35 cases of severe Gram negative neonatal sepsis, with all the organisms resistant to ampicillin, amoxillin, ticarcillin, cefazoline, cefotaxime, ceftazidime, ceftriaxone, and aminoglycoside. They treated these babies with meropenem and achieved 94.3% satisfactory clinical and bacterial response. The routine use of intrapartum antibiotic prophylaxis for the clinical prevention of group B streptococcus septicaemia in newborn babies has resulted in the appearance of ampicillin resistant Gram negative neonatal sepsis in a large number of developed countries. [34] [35] [36] Infection by resistant organisms has been associated with treatment failure, higher morbidity and mortality, and increased costs. Furthermore, excessive antibiotic use causes neonatal fungal sepsis. Studies have consistently shown that the duration of antibiotic use, particularly broad spectrum antibiotics, is a major risk factor for neonatal fungal infection. 13, 14 Neonatal fungal infection has almost exclusively been described in very low birth weight (VLBW) babies weighing <1500 grams at birth. In general, larger babies are almost never affected unless they require prolonged intravenous feeding and or prolonged intubation.
Our study showed 37.3% (122 in 327) neonates affected with fungal infection. About 60% neonates who had fungal infection were premature with birth weights <2000 grams. Rozaliyani's 7 study (2001) (2002) (2003) in the Neonatology Unit at Cipto Mangunkusumo Hospital, reported a total of 52 neonates who had fungal infection, 61.5% were full term and 55.8% had birth weights >2500 grams. Since we had a budget limit, our study was unable to perform resistency and sensitivity tests for fungi. Rozaliyani et al 37 found a total of 135 neonates suspected of sepsis, 85 (62.96%) neonates had fungal infection. Of those who had fungal infection, only 52 neonates underwent sensitivity tests to various drugs. About 30.8% (16 out of 52) neonates had either bacteria or fungal infection. Candida sp were responsible for almost 80.9% of fungal infection episodes, with C. tropicalis as the most common (48.5%) followed by C. guilliermondii (14.7%), C. albicans 11.8%, C. glabrata 4.46%, and C. lusitaniae 1.5%. T. variabile was also isolated for about 19.1%. Rozaliyani 37 also reported that Candida sp showed a higher degree of sensitivity to fluconazole compared to itraconazole.
Unless neonatologists stop using broad spectrum antibiotics for prolonged periods, resistance to antibiotics will rise. Resistance to the carbapenems, imipenem, and meropenem already appears in our unit, while various bacteria are resistant to all other antibiotics. Neonatologists must realize that overuse of broad spectrum antibiotics is irresponsible. The long-term results will be that neonatologists will have no antibiotics left to treat sepsis caused by certain organisms. Specialists in tertiary centers should discontinue using broad spectrum antibiotics for long periods of time and not accuse colleagues in district or private hospitals for misuse of antibiotics which should be selected for highly resistant organisms. All doctors must make a combined and concerned effort to improve prescribing practices.
There is a nine-point plan for antibiotic use. First of all, blood (and perhaps cerebrospinal fluid and/ or urine) should always be taken before starting antibiotics. Second, the narrowest spectrum antibiotics possible is preferable, almost always penicillin (e.g. piperacillin-tazobactam) and an aminoglycoside (e.g. amikacin). Third, it is not advisable to use third generation cephalosporin (e.g. cefotaxim, ceftazidime) or a carbapenem (e.g. meropenem, imipenem). Fourth, the government should develop local and national antibiotic policies to restrict the use of expensive broad spectrum antibiotics like imipenem for emergency treatment. Fifth, the reliance on microbiology laboratory for blood culture results is advisable. Sixth, the raising C-reactive protein (CRP) does not always mean that the infant baby is definitely septic. Seventh, antibiotics can be stopped if blood culture result is negative within 2-3 days. Eighth, long periods of antibiotic use should be avoided. Ninth, nosocomial infection can be prevented by reinforcing infection control, specifically proper hand washing.
